Fifth Third Securities’s AbbVie ABBV Stock Holding History

Fifth Third Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$379K	Buy	+1,448	New	+$371K	0.02%	358

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Fifth Third Securities's ABBV Position: Q3 2026 in Review

Fifth Third Securities opened a new position in AbbVie (ABBV) in Q3 2026: 1,448 shares worth $379K. The stake represents 0.02% of the portfolio and ranks #358 among its holdings.

1,290 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Fifth Third Securities held 1,448 shares of AbbVie worth $379K as of Q3 2026.
AbbVie was a new Fifth Third Securities position in Q3 2026.
AbbVie made up 0.02% of Fifth Third Securities's portfolio in Q3 2026, its #358 holding.
1,290 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Fifth Third Securities's 13F filing for Q3 2026, filed 21 Oct 2026.